Peptide record

TPDB13802

Antibacterial Anticancer Toxicity standard
40 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB13802
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 40-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
SRDSRPVQPRVQPPPPPPKQKPSIYDTPIRRPGGRKTMYA
Physicochemical Analysis
C201H328N64O55S1
NCEHLFW
P
4553.27
11.79
9
2
8
+7
14.91
-1.498
36.50
Mammalian: 1.9 hour Yeast: >20 hour E.coli: >10 hour
2980
65.45
10
Residue Composition
number
1
A
6
R
0
N
2
D
0
C
0
E
3
Q
2
G
0
H
2
I
0
L
3
K
1
M
0
F
11
P
3
S
2
T
0
W
2
Y
2
V
Amino Acid Distribution
A: 1 R: 6 N: 0 D: 2 C: 0 E: 0 Q: 3 G: 2 H: 0 I: 2 L: 0 K: 3 M: 1 F: 0 P: 11 S: 3 T: 2 W: 0 Y: 2 V: 2
Chemical Descriptors
40
C201H328N64O55S1
4553.27
11.79
+7
14.91
-1.498
Evidence Records 1 records
Evidence 1 Activity

Activity

0% Hemolysis
Toxicity
512 µM
Hemolytic Cytotoxic
0% Hemolysis | 512 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Design and Characterization of a Novel Hybrid Antimicrobial Peptide OM19R Based on Oncocin and MDAP-2. | Int J Pept Res Ther | 2019